期刊文献+

平心合剂对心衰易损期患者心率、Galectin-3及生活质量的影响 被引量:3

Effect of Pingxin Mixture on Heart Rate,Galectin-3 and Life Quality of Patients at Vulnerable Period of Heart Failure
下载PDF
导出
摘要 目的:观察平心合剂对心衰易损期患者心率、半乳糖凝集素-3(Galectin-3)及生活质量的影响。方法:本研究共纳入心衰易损期患者81例,按随机数字表法分为观察组41例及对照组40组。对照组予常规治疗,观察组在对照组治疗方案的基础上加平心合剂,共治疗3个月,比较2组患者心率、Galectin-3及明尼苏达生活质量量表(MLHFQ)评分的变化。结果:治疗后,2组Galectin-3水平、平均心率、MLHFQ评分均低于治疗前,差异均有统计学意义(P<0.05)。观察组Galectin-3水平、平均心率、MLHFQ评分均低于对照组,差异均有统计学意义(P<0.05)。结论:平心合剂有助于改善心衰易损期患者临床症状、降低Galectin-3水平及平均心率。 Objective:To observe the effect of Pingxin mixture on heart rate,Galectin-3,and life quality of patients at vulnerable period of heart failure.Methods:A total of 81 cases of patients at vulnerable period of heart failure were enrolled and divided into the observation group and the control group according to the random number table method,41 and 40 cases in each group respectively.The control group was given routine treatment,and the observation group was additionally treated Pingxin mixture based on the treatment of the control group.All groups were treated for three months.The changes in heart rate,Galectin-3,and the scores of Minnesota Living with Heart Failure Questionnaire(MLHFQ)were compared between the two groups.Results:After treatment,the levels of Galectin-3,mean heart rate,and the scores of MLHFQ in the two groups were lower than those before treatment,differences being significant(P<0.05).The levels of Galectin-3,mean heart rate,and the score of MLHFQ in the observation group were lower than those in the control group,differences being significant(P<0.05).Conclusion:Pingxin mixture conduces to improving clinical symptoms of patient at vulnerable period of heart failure,and bring down the level of Galectin-3 and mean heart rate.
作者 陈文霖 徐文峥 张晓芹 陈礼平 潘铨 CHEN Wenlin;XU Wenzheng;ZHANG Xiaoqin;CHEN Liping;PAN Quan(不详)
出处 《新中医》 CAS 2021年第1期43-46,共4页 New Chinese Medicine
基金 丽水市科技计划项目(2017GXY35) 丽水市重点研发计划项目(2019ZDYF23)。
关键词 心衰易损期 平心合剂 半乳糖凝集素-3 心率 明尼苏达生活质量量表 Vulnerable period of heart failure Pingxin mixture Galectin-3 Heart rate Minnesota Living with Heart Failure Questionnaire
  • 相关文献

参考文献6

二级参考文献94

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2吴学思.心率在心血管疾病中的意义[J].中华内科杂志,2006,45(7):601-602. 被引量:67
  • 3中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(1):98-122.
  • 4Fu SF, Zhang JH, Gao XM, et al. Clinical practice of tra- ditional Chinese medicines for chronic heart failure [ J ]. Heart Asia, 2010,2:24 - 27. doi. 10.1136/ha. 2009. 001123.
  • 5Mao J, Hou Y, Shang H, et al. Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF [J] . Trials,2009, 24; 10: 122. doi: 10. 1186/1745 - 6215 - 10 - 122.
  • 6毛静远,李国政,崔小磊,等.中医药治疗心力衰竭用药规律的文献研究[C]//中华中医药学会心病分会,中华中医药学会心病分会第十次全国中医心病学术年会暨吉林省中医药学会心病第二次学术会议论文精选,2008:269-276.
  • 7Li X, Zhang J, Huang J, et al. A Multicenter Randomized Double-Blind Parallel-Group Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients with Chronic Heart Failure[J]. J Am Coll Cardiol,2013, 62 (12) : 1065 - 1072.
  • 8DiFrancesco D.I(f)inhibition:a novel mechanism of action[J].Eur Heart J Suppl,2003,5:19-25.
  • 9姚泰等.生理学[M].2005年8月第一版.人民卫生出版社,2010:109-120.
  • 10Manz M,Reuter M,Lauck G,et al.A single intravenous dose of ivabradine,a novel I(f) inhibitor,lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction[J].Cardiology,2003,100(3):149-155.

共引文献6771

同被引文献36

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部